EGCG causes differential inhibition of NF-κB expression in cancer vs. normal cells, with much lower doses of EGCG needed for cancer cells than for healthy cells to demonstrate the effect, i.e., inhibitory effect on NF-κB is seen predominantly in cancer cells [222]. The gene discussed is NFKB1; the disease is cancer.